The NYSE Welcomes vVARDIS as a Publicly Listed Company

• vVARDIS (NYSE: VVVV) is a Swiss dental tech company offering a drill-free treatment for early tooth decay. • Its flagship product, Curodont Repair Fluoride Plus, uses peptide technology to remineralize enamel without drills or needles. • The treatment has been used on over 2.5 million teeth and is in 20%+ of U.S. dental practices. vVARDIS (NYSE: VVVV), co-founded by Dr. Haley Abivardi and Dr. Goly Abivardi, aims to transform dental care with a drill-free treatment for tooth decay, the world's most common non-communicable disease. Tooth decay affects 2.5 billion people globally, with nearly 90% of U.S. adults having experienced it and 73% reporting dental fear, leading 21% to avoid dentists. The Swiss company's flagship product, Curodont Repair Fluoride Plus, developed over 25 years, uses proprietary peptide technology to repair early-stage decay by supporting natural enamel remineralization—without drills, needles, or fillings. The treatment has already been used on more than 2.5 million teeth and is available in over 20% of U.S. dental practices. vVARDIS recently listed on the NYSE.